Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications

8 Sept 2022

Abstract excerpt

We aim to create a bank of clinical grade cord blood-derived induced pluripotent stem cell lines in order to facilitate clinical research leading to the development of new cellular therapies. Here we present a clear pathway toward the creation of such a resource, within a strong quality framework, and with the appropriate regulatory, government and ethics approvals, along with a dynamic follow-up and re-consent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3D Printing in Biomedical Research
Share to Biomedical Ethics and Regulation
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36073721
DOI: 10.1093/stcltm/szac060

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical ApplicationsPMID 36073721Read ↗

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical ApplicationSemantic proximity Read ↗

Concise Review: Cord Blood Banking, Transplantation and Induced Pluripotent Stem Cell: Success and OpportunitiesSemantic proximity Read ↗

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.Semantic proximity Read ↗

Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells.Semantic proximity Read ↗

The EBiSC iPSC bank for disease studiesSemantic proximity Read ↗

Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple PopulationsSemantic proximity Read ↗

Establishment of the Saudi Bank of Induced Pluripotent Stem Cells (SBiPSCs): A National Platform for iPSC-Based Research and TherapySemantic proximity Read ↗

Establishment of the Saudi Bank of Induced Pluripotent Stem Cells (SBiPSCs): A National Platform for iPSC-Based Research and TherapySemantic proximity Read ↗

Generation of Induced Pluripotent Stem Cells from Human Cord BloodSemantic proximity Read ↗

Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road AheadSemantic proximity Read ↗

Human Finger-Prick Induced Pluripotent Stem Cells Facilitate the Development of Stem Cell BankingSemantic proximity Read ↗

HLA-Based Banking of Induced Pluripotent Stem Cells in Saudi ArabiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.